2.7000
0.0000
(0.00%)
At close: April 17 at 4:06:22 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Operating Expense
4,686
4,686
4,986
2,336
Operating Income
-4,686
-4,686
-4,986
-2,336
Net Non Operating Interest Income Expense
534
534
209
--
Pretax Income
-4,505
-4,505
-4,777
-2,336
Tax Provision
-574
-574
-91
--
Net Income Common Stockholders
-3,931
-3,931
-4,686
-2,336
Diluted NI Available to Com Stockholders
-3,931
-3,931
-4,686
-2,336
Basic EPS
-0.01
-0.01
-0.01
-0.01
Diluted EPS
-0.01
-0.01
-0.01
-0.01
Basic Average Shares
500,000
500,000
500,000
317,227.4130
Diluted Average Shares
500,000
500,000
500,000
317,227.4130
Total Operating Income as Reported
-5,039
-5,039
-4,986
-2,336
Total Expenses
4,686
4,686
4,986
2,336
Net Income from Continuing & Discontinued Operation
-3,931
-3,931
-4,686
-2,336
Normalized Income
-3,622.9771
-3,622.9771
-4,686
-2,336
Interest Income
534
534
209
--
Net Interest Income
534
534
209
--
EBIT
-4,686
-4,686
-4,986
-2,336
EBITDA
-4,660
-4,660
-4,960
-2,318
Reconciled Depreciation
26
26
26
18
Net Income from Continuing Operation Net Minority Interest
-3,931
-3,931
-4,686
-2,336
Total Unusual Items Excluding Goodwill
-353
-353
--
--
Total Unusual Items
-353
-353
--
--
Normalized EBITDA
-4,307
-4,307
-4,960
-2,318
Tax Rate for Calcs
0.0001
0.0001
0
--
Tax Effect of Unusual Items
-44.9771
-44.9771
--
--
12/31/2021 - 7/19/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HVO.L hVIVO plc
16.25
-2.26%
MVR0.BE Medivir AB
0.1372
-2.42%
BT3.BE Lineage Cell Therapeutics Inc
0.3600
-1.10%
HQ1.MU Oruka Therapeutics Inc. R
7.50
+2.04%
05Y.MU Vivoryon Therapeutics NV
1.7140
0.00%
ICY.HA Incyte Corp
51.16
-0.31%
PROT Proteonomix, Inc.
0.0000
0.00%
DBV.F DBV Technologies S.A.
1.2520
+1.79%
HTD.MU Corcept Therapeutics Inc
57.90
-3.60%
TCF.L Theracryf Plc
0.2250
0.00%